Journal of Cancer Therapy
Vol.5 No.5(2014), Paper ID 45181, 7
pages
DOI:10.4236/jct.2014.55052
Cytogenetic Response in Chronic Myeloid Leukaemia Patients Treated with Imatinib Mesylate Homolog-Drugs: 6 Year’s Transitional Study
Najmaddin Khoshnaw, Bassam Francis, Banaz M. Safar, Salim S. Mahmood, Beston F. Nore
Department of Haematology, Hiwa Hospital, Sulaymaniyah, Kurdistan Region, Iraq
Department of Haematology, Baghdad Teaching Hospital (Medical City), Baghdad, Iraq
Department of Haematology, Hiwa Hospital, Sulaymaniyah, Kurdistan Region, Iraq
Departmentof Immunology and Microbiology, Laboratory of Haematopathology and Immunology, Baghdad, Iraq
Department of Biochemistry, Faculty of Medical Sciences, School of Medicine, University of Sulaimani, Sulaymaniyah, Kurdistan Region, Iraq
Copyright © 2014 Najmaddin Khoshnaw, Bassam Francis, Banaz M. Safar, Salim S. Mahmood, Beston F. Nore et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Khoshnaw, N. , Francis, B. , Safar, B. , Mahmood, S. and Nore, B. (2014) Cytogenetic Response in Chronic Myeloid Leukaemia Patients Treated with Imatinib Mesylate Homolog-Drugs: 6 Year’s Transitional Study.
Journal of Cancer Therapy,
5, 453-459. doi:
10.4236/jct.2014.55052.